Trump Administration Reinforces Medicare Drug Price Negotiation Rules
Forbes - Innovation
12 lis 2026, 15:00Tech
1 min read
The Centers for Medicare and Medicaid Services issued a final rule preventing drug manufacturers from resetting statutory negotiation clocks through reformulations.
The final rule targets a common industry tactic where companies reformulate a drug to bypass price caps. This measure ensures that the statutory negotiation clocks remain active, forcing manufacturers to accept lower prices for covered drugs.
Related
Article written by AI
Z.ai GLM-4.7-FlashFree